Abstract
Background
Recently, a new odontogenic tumor has been described, the so-called adenoid ameloblastoma (AdAM). The aim of this review was to determine the clinical and imaging features of AdAM and to describe its main histopathological findings.
Methods
The systematic review included published cases with a diagnosis of AdAM in the gnathic bones, which had sufficient clinical, imaging, and histopathological data to confirm its diagnosis. The following histopathological diagnostic criteria were adopted: presence of ameloblastoma-like components, duct-like structures, spiral cellular condensations, and a cribriform architecture.
Results
Fifteen articles, corresponding to 30 cases of AdAM, were selected. Most cases affected men (63.3%), with a slight preference for the mandible (16:14) and the posterior region of gnathic bones was the most commonly affected site. The mean age at diagnosis was 40.8 years. Clinically, the lesions usually presented as a swelling (53.3%) and, radiographically, as a well-defined radiolucency (33.4%). Surgical resection (40%) was the most frequently adopted treatment and recurrence occurred in 30% of cases. Microscopic examination showed cribriform areas in most AdAM cases (93.3%); duct-like structures and spiral cellular condensations were seen in 100% of the cases.
Conclusion
The small number of reported cases, the existence of erroneous diagnoses, and the adoption of initial conservative management make it difficult to determine whether AdAM has a higher risk of recurrence or more aggressive biological behavior than conventional ameloblastomas.
Similar content being viewed by others
References
Laborde A, Nicot R, Wojcik T et al (2017) Ameloblastoma of the jaws: management and recurrence rate. Eur Ann Otorhinolaryngol Head Neck Dis 134:7–11. https://doi.org/10.1016/j.anorl.2016.09.004
Almeida RAC, Andrade ES, Barbalho JC et al (2016) Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis. Int J Oral Maxillofac Surg 45:359–367. https://doi.org/10.1016/j.ijom.2015.12.016
Oginni FO, Stoelinga PJ, Ajike SA et al (2015) A prospective epidemiological study on odontogenic tumours in a black african population, with emphasis on the relative frequency of ameloblastoma. Int J Oral Maxillofac Surg 44:1099–1105. https://doi.org/10.1016/j.ijom.2015.03.018
Hendra FN, Natsir Kalla DS, Van Cann EM et al (2019) Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis. Oral Dis 25:1683–1696. https://doi.org/10.1111/odi.13014
Hendra FN, Van Cann EM, Helder MN et al (2020) Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Dis 26:12–21. https://doi.org/10.1111/odi.13031
Yang R, Liu Z, Peng C et al (2017) Maxillary ameloblastoma: factors associated with risk of recurrence. Head Neck 39:996–1000. https://doi.org/10.1002/hed.24720
Kelppe J, Hagström J, Sorsa T (2019) Ameloblastoma: a retrospective single institute study of 34 subjects. Acta Odontol Scand 77:82–87. https://doi.org/10.1080/00016357.2018.1532530
El-Naggar AK, Chan JKC, Grandis JR et al (2017) Odontogenic and maxillofacial bone tumours. WHO classification of head and neck tumours, 4th edn. IARC, Lyon, pp 205–260
Kreppel M, Zöller J (2017) Ameloblastoma-Clinical, radiological, and therapeutic findings. Oral Dis 24:63–66. https://doi.org/10.1111/odi.12702
Gneep DR, Bishop JA (2020) Gnepp’s diagnostic surgical pathology of the head and neck, 3rd edn. Elsevier, Amsterdam
Jayasooriya PR, Abeyasinghe WAMUL, Liyanage RLPR et al (2022) Diagnostic Enigma of Adenoid Ameloblastoma: Literature Review based evidence to consider it as a new sub type of Ameloblastoma. Head Neck Pathol 16:344–352. https://doi.org/10.1007/s12105-021-01358-w
WHO Classification of Tumours Editorial Board. Head and neck tumours (2022) Lyon (France): International Agency for Research on Cancer. WHO classification of tumours series, 5th ed. Vol. 9 https://publications.iarc.fr/
Vered M, Wright JM (2022) Update from the 5th edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol 16:63–75. https://doi.org/10.1007/s12105-021-01404-7
Sweeney RT, McClary AC, Myers BR et al (2015) Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet 47(1):97
Soluk-Tekkesin M, Wright JM (2022) The World Health Organization classification of odontogenic lesions: a summary of the changes of the 2022, 5th Edn. Turk Patoloji Derg 38:168–184. https://doi.org/10.5146/tjpath.2022.01573
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
Gagnier JJ, Kienle G, Altman DG et al (2013) The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med 2:38–43. https://doi.org/10.7453/gahmj.2013.008
Adorno-Farias D, Muniz VRVM, Soares AP et al (2018) Ameloblastoma with adenoid features: a series of eight cases. Acta Histochem 120:468–476. https://doi.org/10.1016/j.acthis.2018.05.006
Jofre SA, Roth M, Lahouti AH et al (2022) Ameloblastoma with adenoid features: case report with cyto-histopathologic correlation and molecular findings. Diagn Cytopathol 50:E140–E145. https://doi.org/10.1002/dc.24929
Khalele BAO, Al-Shiaty RA (2016) Adenoid ameloblastoma with dentinoid and cellular atypia: a rare case report. Ital J Med 10:238–240. https://doi.org/10.4081/itjm.2016.639
Loyola AM, Cardoso SV, de Faria PR et al (2015) Adenoid ameloblastoma: clinicopathologic description of five cases and systematic review of the current knowledge. Oral Surg Oral Med Oral Pathol Oral Radiol 120:368–377. https://doi.org/10.1016/j.oooo.2015.05.011
Coura BP, Dos Santos JN, Fonseca FP et al (2021) Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors. J Oral Pathol Med 50:1067–1071. https://doi.org/10.1111/jop.13243
Tajima Y, Sakamoto E, Yamamoto Y (1992) Odontogenic cyst giving rise to an adenomatoid odontogenic tumor: report of a case with peculiar features. J Oral Maxillofac Surg 50:190–193. https://doi.org/10.1016/0278-2391(92)90370-f
Matsumoto Y, Mizoue K, Seto K (2001) Atypical plexiform ameloblastoma with dentinoid: adenoid ameloblastoma with dentinoid. J Oral Pathol Med 30:251–254. https://doi.org/10.1034/j.1600-0714.2001.300410.x
Evans BL, Carr RF, Phillipe LJ (2004) Adenoid ameloblastoma with dentinoid: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:583–588. https://doi.org/10.1016/j.tripleo.2004.02.077
Ide F, Mishima K, Saito I, Kusama K (2009) Diagnostically challenging epithelial odontogenic tumors: a selective review of 7 jawbone lesions. Head Neck Pathol 3:18–26. https://doi.org/10.1007/s12105-009-0107-4
Saxena K, Jose M, Chatra LK, Sequiera J (2012) Adenoid ameloblastoma with dentinoid. J Oral Maxillofac Pathol 16:272–276. https://doi.org/10.4103/jomfp.JOMFP_53_15
Pandiar D, Gopinath D (2022) Adenoid ameloblastoma: the histological paradox. Head Neck Pathol 16:538–539. https://doi.org/10.1007/s12105-021-01372-y
Brown NA, Rolland D, McHugh JB et al (2014) Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res 20:5517–5526. https://doi.org/10.1158/1078-0432.CCR-14-1069
Sweeney RT, McClary AC, Myers BR et al (2014) Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet 46:722–725. https://doi.org/10.1038/ng.2986
Gondak RO, Mariano FV, de Sousa SF et al (2020) CTNNB1 and APC mutations in odontogenic carcinoma with dentinoid. Oral Surg Oral Med Oral Pathol Oral Radiol 129:e249–e256. https://doi.org/10.1016/j.oooo.2019.08.017
Gomes CC, de Sousa SF, de Menezes GH et al (2016) Recurrent KRAS G12V pathogenic mutation in adenomatoid odontogenic tumours. Oral Oncol 56:e3–e5. https://doi.org/10.1016/j.oraloncology.2016.03.001
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Contributions
HGFM: conceptualization, data curation, formal analysis, investigation, methodology resources, software, validation, visualization, roles/writing—original draft, and writing—review and editing. RICG: data curation, formal analysis, visualization, and roles/writing—original draft. CSOC: data curation, formal analysis, visualization, and roles/writing—original draft. HFP: investigation and roles/writing—original draft. RPM: writing—review and editing, investigation, and roles/writing—original draft. EFM: writing—review and editing, investigation, and roles/writing—original draft. MCCM: project administration, visualization, and writing—review and editing. RAF: formal analysis, investigation, methodology resources, visualization, and writing—review and editing.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
For this type of study informed consent is not required.
Consent for Publication
For this type of study consent for publication is not required.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
12105_2023_1574_MOESM2_ESM.docx
Supplementary Table 2.Summary of histopathological and molecular data of the studies included in thesystematic review (DOCX 31.6 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
de Farias Morais, H.G., Gonçalo, R.I.C., de Oliveira Costa, C.S. et al. A Systematic Review of Adenoid Ameloblastoma: A Newly Recognized Entity. Head and Neck Pathol 17, 688–696 (2023). https://doi.org/10.1007/s12105-023-01574-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-023-01574-6